Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;41(12):2227-2234.
doi: 10.3174/ajnr.A6848. Epub 2020 Nov 5.

Development and Validation of a Deep Learning-Based Automatic Brain Segmentation and Classification Algorithm for Alzheimer Disease Using 3D T1-Weighted Volumetric Images

Affiliations

Development and Validation of a Deep Learning-Based Automatic Brain Segmentation and Classification Algorithm for Alzheimer Disease Using 3D T1-Weighted Volumetric Images

C H Suh et al. AJNR Am J Neuroradiol. 2020 Dec.

Abstract

Background and purpose: Limited evidence has suggested that a deep learning automatic brain segmentation and classification method, based on T1-weighted brain MR images, can predict Alzheimer disease. Our aim was to develop and validate a deep learning-based automatic brain segmentation and classification algorithm for the diagnosis of Alzheimer disease using 3D T1-weighted brain MR images.

Materials and methods: A deep learning-based algorithm was developed using a dataset of T1-weighted brain MR images in consecutive patients with Alzheimer disease and mild cognitive impairment. We developed a 2-step algorithm using a convolutional neural network to perform brain parcellation followed by 3 classifier techniques including XGBoost for disease prediction. All classification experiments were performed using 5-fold cross-validation. The diagnostic performance of the XGBoost method was compared with logistic regression and a linear Support Vector Machine by calculating their areas under the curve for differentiating Alzheimer disease from mild cognitive impairment and mild cognitive impairment from healthy controls.

Results: In a total of 4 datasets, 1099, 212, 711, and 705 eligible patients were included. Compared with the linear Support Vector Machine and logistic regression, XGBoost significantly improved the prediction of Alzheimer disease (P < .001). In terms of differentiating Alzheimer disease from mild cognitive impairment, the 3 algorithms resulted in areas under the curve of 0.758-0.825. XGBoost had a sensitivity of 68% and a specificity of 70%. In terms of differentiating mild cognitive impairment from the healthy control group, the 3 algorithms resulted in areas under the curve of 0.668-0.870. XGBoost had a sensitivity of 79% and a specificity of 80%.

Conclusions: The deep learning-based automatic brain segmentation and classification algorithm allowed an accurate diagnosis of Alzheimer disease using T1-weighted brain MR images. The widespread availability of T1-weighted brain MR imaging suggests that this algorithm is a promising and widely applicable method for predicting Alzheimer disease.

PubMed Disclaimer

Figures

FIG 1.
FIG 1.
Network architecture of the brain parcellation and classification model. CONV indicates convolution.
FIG 2.
FIG 2.
The impact of feature (volume of each brain region) on the AD prediction model, as represented by Shapley values, in which the impact of a feature is defined as the change in the expected output of the model when a feature is observed versus unknown. A, Visualization of the top 5 brain regions representing feature impacts pushing the decision of the model to AD, along with average feature impact. B, Visualization of the top 5 brain regions representing feature impacts pushing the decision of the model to healthy controls, along with average feature impact. Bankssts indicates banks of the superior temporal sulcus; SHAP, Shapley Additive Explanations (https://pbiecek.github.io/ema/shapley.html).

References

    1. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr 2008;13:45–53 10.1017/s1092852900016151 - DOI - PubMed
    1. Dubois B, Feldman HH, Jacova C, et al. . Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734–46 10.1016/S1474-4422(07)70178-3 - DOI - PubMed
    1. McKhann GM, Knopman DS, Chertkow H, et al. . The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263–69 10.1016/j.jalz.2011.03.005 - DOI - PMC - PubMed
    1. Jack CR Jr, Bennett DA, Blennow K, et al.; Contributors. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement 2018;14:535–62 10.1016/j.jalz.2018.02.018 - DOI - PMC - PubMed
    1. Johnson KA, Schultz A, Betensky RA, et al. . Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 2016;79:110–19 10.1002/ana.24546 - DOI - PMC - PubMed

Publication types